RxDoctor Payments Data

Peter Drummond, DO

Internal Medicine · Stockton, CANPI 1508822768

Payments from drug & device makers

$201in general payments, 2019–2025

Across 15 payments — averaging $13.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$63
  • E.r. Squibb & Sons, L.L.C.$59
  • Novo Nordisk$40
  • Amarin Pharma, Inc.$15
  • Lilly USA, LLC$13
  • Boston Scientific$11

What the payments were for

  • Food & beverage$201100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$201 in reported general payments places this provider in the 50th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$332,115
Medicare patients
821
Services billed
3,919

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin131$137,956
EliquisApixaban176$130,037
MounjaroTirzepatide51$61,546
OzempicSemaglutide56$59,151
JanuviaSitagliptin Phosphate59$46,040
XareltoRivaroxaban38$33,277
TrulicityDulaglutide20$33,162
MyrbetriqMirabegron31$22,856
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen512$12,413
PremarinEstrogens, Conjugated26$12,272
Fentanyl41$10,427
Atorvastatin Calcium908$9,040
Tresiba Flextouch U-100Insulin Degludec19$8,954
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$6,880
FarxigaDapagliflozin Propanediol12$5,989

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin, Paxlovid$63$145,106226 claims
Lilly USA, LLCMounjaro, Trulicity$13$94,70871 claims
Novo NordiskOzempic$40$59,15156 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 13,581 internal medicine providers in California.

Other internal medicine in Stockton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →